Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation Group.

45 In addition, availability and cost may be significant barriers to the use of FDC medication 46 and validated automatic BP devices, 47 but the evidence behind both of these drivers is strong enough (and now endorsed by the updated WHO guideline) to support their inclusion as key drivers that all health systems should aspire to implement.

also in 13,097 other papers